259 related articles for article (PubMed ID: 28861639)
21. Proton-Potassium (H(+)/K(+)) ATPases: Properties and Roles in Health and Diseases.
Sakai H; Fujii T; Takeguchi N
Met Ions Life Sci; 2016; 16():459-83. PubMed ID: 26860309
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety.
Savarino V; Di Mario F; Scarpignato C
Pharmacol Res; 2009 Mar; 59(3):135-53. PubMed ID: 18977444
[TBL] [Abstract][Full Text] [Related]
23. Proton pump inhibitors: actions and reactions.
Mullin JM; Gabello M; Murray LJ; Farrell CP; Bellows J; Wolov KR; Kearney KR; Rudolph D; Thornton JJ
Drug Discov Today; 2009 Jul; 14(13-14):647-60. PubMed ID: 19443264
[TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitors as also inhibitors of atrial fibrillation.
Lin K; Chen X; Zhang L; Wang Y; Shan Z
Eur J Pharmacol; 2013 Oct; 718(1-3):435-40. PubMed ID: 23973848
[TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitors interfere with the anti-tumor potency of RC48ADC.
Zhang X; Wang Y; Luo W; Zhu MM; Huang C
Toxicol In Vitro; 2022 Mar; 79():105292. PubMed ID: 34871754
[TBL] [Abstract][Full Text] [Related]
26. Proton pump inhibitors as anti vacuolar-ATPases drugs: a novel anticancer strategy.
Spugnini EP; Citro G; Fais S
J Exp Clin Cancer Res; 2010 May; 29(1):44. PubMed ID: 20459683
[TBL] [Abstract][Full Text] [Related]
27. Proton pump inhibitors in IPF: beyond mere suppression of gastric acidity.
Ghebre Y; Raghu G
QJM; 2016 Sep; 109(9):577-579. PubMed ID: 27647940
[TBL] [Abstract][Full Text] [Related]
28. Consequences of Hypoacidity Induced by Proton Pump Inhibitors - a Practical Approach.
Rychlíčková J
Klin Onkol; 2018; 31(6):409-413. PubMed ID: 31035765
[TBL] [Abstract][Full Text] [Related]
29. Proton Pump Inhibitors in cancer patients: How useful they are? A review of the most common indications for their use.
Numico G; Fusco V; Franco P; Roila F
Crit Rev Oncol Hematol; 2017 Mar; 111():144-151. PubMed ID: 28259289
[TBL] [Abstract][Full Text] [Related]
30. The Evaluation of Potential Cytotoxic Effect of Different Proton Pump Inhibitors on Different Human Cancer Cell Lines.
Qasem A; Kasabri V; AbuRish E; Bustanji Y; Al-Hiari Y; Al-Abbasi R; Abu-Irmaileh B; Alalawi S
Anticancer Agents Med Chem; 2020; 20(2):245-253. PubMed ID: 31663482
[TBL] [Abstract][Full Text] [Related]
31. Proton pump inhibitors display anti-tumour potential in glioma.
Li B; Liu Y; Sun S
Cell Prolif; 2023 Jul; 56(7):e13321. PubMed ID: 35961680
[TBL] [Abstract][Full Text] [Related]
32. Stereoselective Pharmacodynamics and Pharmacokinetics of Proton Pump Inhibitors.
Yang ZC; Yu F; Wang YQ; Wei JF
Curr Drug Metab; 2016; 17(7):692-702. PubMed ID: 27683046
[TBL] [Abstract][Full Text] [Related]
33. Proton pump inhibitors--their pharmacological impact on the clinical management of acid-related disorders.
Klotz U
Arzneimittelforschung; 2009; 59(6):271-82. PubMed ID: 19634508
[TBL] [Abstract][Full Text] [Related]
34. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal.
Savarino V; Dulbecco P; de Bortoli N; Ottonello A; Savarino E
Eur J Intern Med; 2017 Jan; 37():19-24. PubMed ID: 27784575
[TBL] [Abstract][Full Text] [Related]
35. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.
Luciani F; Spada M; De Milito A; Molinari A; Rivoltini L; Montinaro A; Marra M; Lugini L; Logozzi M; Lozupone F; Federici C; Iessi E; Parmiani G; Arancia G; Belardelli F; Fais S
J Natl Cancer Inst; 2004 Nov; 96(22):1702-13. PubMed ID: 15547183
[TBL] [Abstract][Full Text] [Related]
36. Network pharmacology analysis reveals potential targets and mechanisms of proton pump inhibitors in breast cancer with diabetes.
Hu H; Wang H; Yang X; Li Z; Zhan W; Zhu H; Zhang T
Sci Rep; 2023 May; 13(1):7623. PubMed ID: 37165049
[TBL] [Abstract][Full Text] [Related]
37. Is it safe to use a proton pump inhibitor with clopidogrel?
Chow CK; Moayyedi P; Devereaux PJ
Pol Arch Med Wewn; 2009 Sep; 119(9):564-8. PubMed ID: 19776701
[TBL] [Abstract][Full Text] [Related]
38. [Clinical use of proton pump inhibitors in gastrointestinal diseases].
Rew JS
Korean J Gastroenterol; 2006 Mar; 47(3):181-90. PubMed ID: 16554671
[TBL] [Abstract][Full Text] [Related]
39. Drug-drug interactions with proton pump inhibitors in cancer patients: an underrecognized cause of treatment failure.
Raoul JL; Moreau-Bachelard C; Gilabert M; Edeline J; Frénel JS
ESMO Open; 2023 Feb; 8(1):100880. PubMed ID: 36764092
[TBL] [Abstract][Full Text] [Related]
40. CYP2C19 genotypes in the pharmacokinetics/pharmacodynamics of proton pump inhibitor-based therapy of Helicobacter pylori infection.
Yang JC; Lin CJ
Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):29-41. PubMed ID: 19968574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
